ARID1A and hairy cell leukemia: Recurrent mutations in the genes coding for the enhancer of Zeste 2 (EZH2), AT-rich interaction domain 1A (ARID1A), and cyclin-dependent kinase inhibitor 1B (CDKN1B) have also been identified in patients with HCL resistant to purine analogues (11).